Komori
Annual Securities Report4591RIBOMIC Inc.Pharmaceuticals

Annual Securities Report — FY2025

What RIBOMIC Inc. reported for the period from 2025-04-01 to 2026-03-31.

How much it says
54Typical
What moved here
36named for the first time
Its own wording
59terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the fiscal year, operating losses and net losses continued, driven mainly by R&D expenses, while cash and cash equivalents increased from the end of the previous year. The company also issued and partially exercised the 18th through 20th stock acquisition rights, with adjustment provisions for the exercise price, to fund its operations.

Komori's summary of this document, not the document's own words.
54Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 36 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
Magnitude of Change
68
Detailed
Strategic Shift
70
Detailed
Capital Movement
38
Thin
Disclosure Gaps
0
Almost nothing
Concentration Risk
41
Thin
Future Commitments
68
Detailed
Change in Risk
55
Typical
Financial and Capital Policy
60
Detailed
Product Portfolio
55
Typical
Technology Position
50
Typical
Confidence in Strategic Bets
R&D spend8億円Money spent making new things.
Cash left over-8億円Cash from the business, less what went into equipment.
Spent on equipment9百万円Plants, machines — things meant to last.
Employees25Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
RIBOMIC Inc. — FY2025 | Komori